FTDI
ABMD

First Trust Direct Indexing’s Abiomed Inc ABMD Stock Holding History

First Trust Direct Indexing’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,145
Closed -$281K – 713
2022
Q3 		$281K Buy
1,145
+89
+8% +$24K 0.04% 487
2022
Q2 		$261K Buy
+1,056
New +$285K 0.04% 512

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Trust Direct Indexing's ABMD Position: Q4 2022 in Review

First Trust Direct Indexing sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,145 shares — an estimated $281K sold.

First Trust Direct Indexing first reported a position in ABMD in Q2 2022 and held it in 2 quarters. The position peaked at $281K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • First Trust Direct Indexing reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • First Trust Direct Indexing sold 1,145 Abiomed Inc shares in Q4 2022, an estimated $281K.
  • First Trust Direct Indexing first reported a position in Abiomed Inc in Q2 2022 and held it in 2 quarters.
  • First Trust Direct Indexing's Abiomed Inc position peaked at $281K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on First Trust Direct Indexing's 13F filing for Q4 2022, filed 20 Jan 2023.